(210) | Number of the EPO application | 17794593 |
(220) | Filing date of the EPO application | 2017.10.24 |
(80) | EPO patent specification publication (B) | EPB nr. 18/2021, 2021.05.05 |
(110) | EPO patent number | 3532499 |
(11) | Number of the document | MD 3532499 T2 |
(21) | Number of the application | e 2019 0980 |
(71) | Name(s) of applicant(s), code of the country | ELI LILLY AND COMPANY, US; |
(72) | Name(s) of inventor(s), code of the country | BENSCHOP Robert Jan, US; DAVIES Julian, US; OKRAGLY Angela Jeannine, US; PATEL Chetankumar Natvarlal, US; TRUHLAR Stephanie Marie, US; |
(73) | Name(s) of owner(s), code of the country | ELI LILLY AND COMPANY, US; |
(54) | Title of the invention | Anti-IL-33 antibodies and uses thereof |
(13) | Kind-of-document code | T2 |
(51) | International Patent Classification | A61P 1/00 (2006.01.01); A61P 11/00 (2006.01.01); A61P 11/06 (2006.01.01); A61P 17/00 (2006.01.01); C07K 16/24 (2006.01.01); A61P 37/08 (2006.01.01) |
(19) | Country | US |
(41) | Date of publication of the application | 2019.10.31 |
(49) | Date of publication of the translation of the validated European patent specification | 2021.09.30 |
(30) | Priority | 201662414258 P, 2016.10.28, US |
(74) | Patent attorney | (Procedură) LAZICOV Tatiana, str. A. Pușkin nr. 33, ap. 73, MD-2012, Chișinau, Republica Moldova |
(86) | International application | PCT/US2017/058020, 2017.10.24 |
(87) | International publication | WO 2018/081075, 2018.05.03 |